557 related articles for article (PubMed ID: 21932400)
21. MRI findings of hepatocellular carcinoma.
Wiwanitkit V
Magn Reson Imaging; 2011 Feb; 29(2):303. PubMed ID: 21129874
[No Abstract] [Full Text] [Related]
22. MRI findings of rapidly progressive hepatocellular carcinoma.
Kierans AS; Leonardou P; Hayashi P; Brubaker LM; Elazzazi M; Shaikh F; Semelka RC
Magn Reson Imaging; 2010 Jul; 28(6):790-6. PubMed ID: 20427139
[TBL] [Abstract][Full Text] [Related]
23. Liver lesion characterization: the wrong choice of contrast agent can mislead the diagnosis of hemangioma.
Pradella S; Lucarini S; Colagrande S
AJR Am J Roentgenol; 2012 Nov; 199(5):W662. PubMed ID: 23096214
[No Abstract] [Full Text] [Related]
24. MultiHance in the dynamic phase of contrast enhancement: a pictorial assessment.
Grazioli L; Kirchin M; Pirovano G; Spinazzi A
J Comput Assist Tomogr; 1999 Nov; 23 Suppl 1():S61-4. PubMed ID: 10608399
[TBL] [Abstract][Full Text] [Related]
25. Gadoxetic acid-enhanced hepatobiliary phase MR imaging: cellular insight.
Pastor CM
Radiology; 2010 Nov; 257(2):589. PubMed ID: 20959554
[No Abstract] [Full Text] [Related]
26. Can the patient with cirrhosis be imaged for hepatocellular carcinoma without gadolinium?: Comparison of combined T2-weighted, T2*-weighted, and diffusion-weighted MRI with gadolinium-enhanced MRI using liver explantation standard.
Hardie AD; Kizziah MK; Rissing MS
J Comput Assist Tomogr; 2011; 35(6):711-5. PubMed ID: 22082541
[TBL] [Abstract][Full Text] [Related]
27. Imaging of paediatric liver tumours with pathological correlation.
Das CJ; Dhingra S; Gupta AK; Iyer V; Agarwala S
Clin Radiol; 2009 Oct; 64(10):1015-25. PubMed ID: 19748008
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic accuracy of MRI in differentiating hepatocellular adenoma from focal nodular hyperplasia: prospective study of the additional value of gadoxetate disodium.
Bieze M; van den Esschert JW; Nio CY; Verheij J; Reitsma JB; Terpstra V; van Gulik TM; Phoa SS
AJR Am J Roentgenol; 2012 Jul; 199(1):26-34. PubMed ID: 22733890
[TBL] [Abstract][Full Text] [Related]
29. Gadobenate dimeglumine-enhanced liver magnetic resonance imaging: value of hepatobiliary phase for the detection of focal liver lesions.
Fu GL; Du Y; Zee CS; Yang HF; Li Y; Duan RG; Zeng NL; Xiao DM
J Comput Assist Tomogr; 2012; 36(1):14-9. PubMed ID: 22261765
[TBL] [Abstract][Full Text] [Related]
30. Characterizing focal hepatic lesions by free-breathing intravoxel incoherent motion MRI at 3.0 T.
Watanabe H; Kanematsu M; Goshima S; Kajita K; Kawada H; Noda Y; Tatahashi Y; Kawai N; Kondo H; Moriyama N
Acta Radiol; 2014 Dec; 55(10):1166-73. PubMed ID: 24316660
[TBL] [Abstract][Full Text] [Related]
31. Review article: the evaluation of solitary liver masses.
Bahirwani R; Reddy KR
Aliment Pharmacol Ther; 2008 Oct; 28(8):953-65. PubMed ID: 18643922
[TBL] [Abstract][Full Text] [Related]
32. [Evaluation of Gd-BOPTA and Gd-DTPA in contrast-enhanced MR imaging of the liver].
Zhang HM; Ouyang H; Zhou CW
Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):111-5. PubMed ID: 16750014
[TBL] [Abstract][Full Text] [Related]
33. [MR diagnosis of focal liver lesions].
Palkó A
Orv Hetil; 2004 Feb; 145(7 Suppl 1):374-7. PubMed ID: 15049054
[TBL] [Abstract][Full Text] [Related]
34. Contrast-enhanced ultrasound (CEUS) for the characterization of focal liver lesions in clinical practice (DEGUM Multicenter Trial): CEUS vs. MRI--a prospective comparison in 269 patients.
Seitz K; Bernatik T; Strobel D; Blank W; Friedrich-Rust M; Strunk H; Greis C; Kratzer W; Schuler A
Ultraschall Med; 2010 Oct; 31(5):492-9. PubMed ID: 20652854
[TBL] [Abstract][Full Text] [Related]
35. [MRI in the differential diagnosis of liver focal lesions].
Negru D; Fotea V; Grigoraş M; Moisii L; Daniil C
Rev Med Chir Soc Med Nat Iasi; 2006; 110(3):548-54. PubMed ID: 17571543
[TBL] [Abstract][Full Text] [Related]
36. Utility of diffusion-weighted MRI in distinguishing benign and malignant hepatic lesions.
Miller FH; Hammond N; Siddiqi AJ; Shroff S; Khatri G; Wang Y; Merrick LB; Nikolaidis P
J Magn Reson Imaging; 2010 Jul; 32(1):138-47. PubMed ID: 20578020
[TBL] [Abstract][Full Text] [Related]
37. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
[TBL] [Abstract][Full Text] [Related]
38. Assessment of diffusion-weighted imaging for characterizing focal liver lesions.
Parsai A; Zerizer I; Roche O; Gkoutzios P; Miquel ME
Clin Imaging; 2015; 39(2):278-84. PubMed ID: 25433855
[TBL] [Abstract][Full Text] [Related]
39. Focal liver lesion detection and characterization with GD-EOB-DTPA.
Purysko AS; Remer EM; Veniero JC
Clin Radiol; 2011 Jul; 66(7):673-84. PubMed ID: 21524416
[TBL] [Abstract][Full Text] [Related]
40. Contrast-Enhanced Ultrasound (CEUS) for the characterization of focal liver lesions - prospective comparison in clinical practice: CEUS vs. CT (DEGUM multicenter trial). Parts of this manuscript were presented at the Ultrasound Dreiländertreffen 2008, Davos.
Seitz K; Strobel D; Bernatik T; Blank W; Friedrich-Rust M; Herbay Av; Dietrich CF; Strunk H; Kratzer W; Schuler A
Ultraschall Med; 2009 Aug; 30(4):383-9. PubMed ID: 19688670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
